KBC Group’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-234,554
Closed -$1.45M 1349
2018
Q3
$1.45M Buy
234,554
+234,040
+45,533% +$1.06M 0.01% 798
2018
Q2
$3K Sell
514
-1,000
-66% -$7.12K ﹤0.01% 1288
2018
Q1
$11K Buy
1,514
+1,000
+195% +$11.6K ﹤0.01% 1261
2017
Q4
$6K Buy
+514
New +$6.27K ﹤0.01% 1255
2016
Q3
Sell
-22,508
Closed -$180K 1301
2016
Q2
$180K Buy
+22,508
New +$175K ﹤0.01% 1099

Other funds holding MDXG

KBC Group's MDXG Position: Q4 2018 in Review

KBC Group sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 234,554 shares — an estimated $1.45M sold.

KBC Group first reported a position in MDXG in Q2 2016 and held it in 5 quarters. The position peaked at $1.45M in Q3 2018. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

  • KBC Group reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
  • KBC Group sold 234,554 MiMedx Group shares in Q4 2018, an estimated $1.45M.
  • KBC Group first reported a position in MiMedx Group in Q2 2016 and held it in 5 quarters.
  • KBC Group's MiMedx Group position peaked at $1.45M in Q3 2018.
  • 38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on KBC Group's 13F filing for Q4 2018, filed 31 Jan 2019.